OpenLB
Open Library of Bioscience
Advanced Search
The New England journal of medicine
Jun 22, 2023;388 (25): 2395.

VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.

Felix Bergmann, Anselm Jorda, Markus Zeitlinger
Author Information
  1. Felix Bergmann: Medical University of Vienna, Vienna, Austria.
  2. Anselm Jorda: Medical University of Vienna, Vienna, Austria.
  3. Markus Zeitlinger: Medical University of Vienna, Vienna, Austria.
PMID: 37342931 DOI: 10.1056/NEJMc2305030

Abstract

No abstract text available.

MeSH Term

Humans
Ritonavir
COVID-19
COVID-19 Drug Treatment

Chemicals

nirmatrelvir
Ritonavir
GS-621763
Letter Comment

Word Cloud

Created with Highcharts 10.0.0VV116Nirmatrelvir-RitonavirOralTreatmentCovid-19

Similar Articles

Cited By